9 completed, 1 terminated. 7 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 6, Terminated 1 |
| Phase 1 | 3 | Completed 3 |
Follow SB 705498: new trials by email Literature Review of SB 705498 trials Research Report on SB 705498
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of Topical SB705498 on Healthy Volunteers SB705498, Placebo - Dermatitis, Atopic | Phase 1 | Completed | GlaxoSmithKline | 16 | 2012-07-17 | 2017-06-09 |
| Intranasal SB-705498 in Allergic Rhinitis (AR) Patients SB-705498, FP, placebo - Rhinitis | Phase 2 | Completed | GlaxoSmithKline | 70 | 2011-04-14 | 2019-09-13 |
| A Study to Investigate the Effect of SB-705498 on Chronic Cough Placebo, SB-705498 - Rhinitis | Phase 2 | Completed | GlaxoSmithKline | 21 | 2011-04-01 | 2016-12-01 |
| SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis SB-705498, Placebo - Rhinitis | Phase 2 | Completed | GlaxoSmithKline | 40 | 2010-12-01 | 2018-01-29 |
| Intranasal SB-705498 in Non-allergic Rhinitis Patients Placebo, SB-705498 - Rhinitis | Phase 2 | Completed | GlaxoSmithKline | 40 | 2009-12-01 | 2016-12-01 |
| Intranasal SB-705498 in Healthy Volunteers SB-705498, Placebo - Rhinitis | Phase 1 | Completed | GlaxoSmithKline | 44 | 2008-11-10 | 2017-07-13 |
| A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model SB-705498, Placebo, Caspaicin - Rhinitis | Phase 1 | Completed | GlaxoSmithKline | 45 | 2008-07-22 | 2017-07-13 |
| Sb-705498 Rectal Pain Study SB-705498 - Irritable Colon | Phase 2 | Terminated | GlaxoSmithKline | 1 | 2007-01-26 | 2018-08-20 |
| Use Of SB-705498 In The Acute Treatment Of Migraine SB-705498 - Migraine, Acute | Phase 2 | Completed | GlaxoSmithKline | 70 | 2006-01-01 | 2009-05-18 |
| SB-705498 Dental Pain Study After Tooth Extraction SB705498 400 mg, SB705498 1000 mg, Placebo - Toothache | Phase 2 | Completed | GlaxoSmithKline | 145 | 2005-12-07 | 2019-01-28 |
Rhinitis (6) · Acute Pain (1) · Dermatitis, Atopic (1) · Inflammation (1) · Irritable Bowel Syndrome (1) · Migraine Disorders (1) · Pruritus (1) · Toothache (1)
GlaxoSmithKline (10)
United Kingdom (6) · Netherlands (3) · Canada (2) · Australia (1) · Austria (1) · Italy (1) · South Korea (1)